To support the health care team’s strategies to integrate new therapies for patients with hemophilia A, this education addresses the following learning objectives, improving learners’ abilities to:

1. Compare and contrast safety and efficacy data for prophylactic treatment approaches in patients with hemophilia A
2. Apply this information into care decisions for patients with hemophilia A
3. Develop a team-based approach to integrating new therapies into current care practices for patients with hemophilia A

This survey is an optional tool and trainers are encouraged to ask their teams to complete it, in order to help tailor content to their specific needs. It can also be used before and after a team training session, to serve as a baseline and follow-up assessment for gains in knowledge and confidence.

These 5 modules can be accessed by the HTC team members individually or can be used during group education sessions, in order to ensure that all team members have the necessary foundational knowledge prior to engaging in discussions on how to integrate new therapies into practice. Each module is ~30 minutes and is available for AMA PRA Category 1 Credits™.

The Change Guides enable trainers and their HTC care teams to explore potential barriers, synergies, and necessary resources needed to make changes within their clinical care approach related to new therapies, and to develop actionable plans.